Cartesian Therapeutics
RNAC
#7523
Rank
โ‚ฌ0.26 B
Marketcap
10,29ย โ‚ฌ
Share price
11.28%
Change (1 day)
-15.03%
Change (1 year)

Revenue for Cartesian Therapeutics (RNAC)

Revenue in 2024 (TTM): โ‚ฌ36.22 Million

According to Cartesian Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ35.6 Million. an increase over the revenue in the year 2023 that were of โ‚ฌ23.52 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cartesian Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ37.39 M58.97%
2023 โ‚ฌ23.52 M-77.22%
2022 โ‚ฌ0.10 B37.47%
2021 โ‚ฌ75.12 M456.73%
2020 โ‚ฌ13.49 M126.39%
2019 โ‚ฌ5.96 M655.11%
2018 โ‚ฌ0.78 M357.53%
2017 โ‚ฌ0.17 M-97.75%
2016 โ‚ฌ7.68 M39.78%
2015 โ‚ฌ5.49 M